Bacterial contamination of platelet concentrates: Incidence, significance, and prevention

Seminars in Hematology

Volumn 38, Issue 4 SUPPL. 11, 2001, Pages 20-26

  Blajchman, Morris A ^a,c   Goldman, Mindy ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HÉMA QUÉBEC   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

BLOOD TRANSFUSION REACTION; CONTAMINATION; DISEASE TRANSMISSION; ERYTHROCYTE; HUMAN; INCIDENCE; INFECTION CONTROL; MORBIDITY; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPSIS; THROMBOCYTE TRANSFUSION;

EID: 0035189684     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0037-1963(01)90120-9     Document Type: Review

References (43)

1. Fatal transfusion reactions from massive bacterial contamination of blood
2. Bacterial contamination
3. Bacterial contamination and proliferation during the storage of cellular blood products
4. Bacterial contamination of blood components
5. Reports of 355 transfusion-associated deaths: 1976 Through 1985
6. Transfusion-associated fatalities: Review of Bureau of Biologics reports 1976-1978
7. Bacteria in the blood supply: An overlooked issue in transfusion medicine
8. A prospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites
9. Reducing the risk of bacterial contamination of cellular blood components
10. Strategies for the avoidance of bacterial contamination of blood components
11. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components
12. Septic reactions to platelet transfusions
13. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets
14. A prospective study on symptomatic bacteremia from platelet transfusion and its management
15. A prospective study to determine the frequency of bacterial contamination in random donor platelet concentrates
16. Bacterial surveillance of platelet concentrates: Quantitation of bacterial load
17. Reduction of platelet transfusion-associated sepsis by short term bacterial culture
18. Bacterial contamination of blood components: Is it in the bag?
19. The serious hazards of transfusion (SHOT) initiative: The UK approach to haemovigilance
20. The French Haemovigilance system
21. A fatal case of transfusion-transmitted Staphylococcus epidermidis sepsis
22. Transfusion-transmitted Yersinia enterocolitica infection in New Zealand
23. Screening blood donors for gastrointestinal illness: A strategy to eliminate carriers of Yersinia enterocolitica
24. Evaluation of donor skin disinfection methods
25. Evaluation of donor arm disinfection techniques
26. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations
27. Determination of the degree of bacterial contamination of whole-blood collections using an automated microbe-detection system
28. Novel platelet products and substitutes
29. Reduction by in-line leukocyte filtration of bacterial contaminants is more effective after an 8-hour hold at 22°C than at 4°C
30. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology
31. Single-donor platelets reduce the risk of septic transfusion reactions
32. The photodecontamination of cellular blood components: Mechanisms and use of photosensitization in transfusion medicine
33. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives
34. Progress in improving the pathogen safety of red cell concentrates
35. The use of riboflavin for the inactivation of pathogens in blood products
36. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light
37. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats
38. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes
39. Demonstration of in vivo hemostatic efficacy of human PCT platelets using a thrombocytopenic rabbit bleeding time model
40. Viability and hemostatic function of photochemically treated platelets in thrombocytopenic patients
41. TM) photochemically treated platelets are safe and effective for support of thrombocytopenia: Results of the euroSPRITE phase 3 trial
42. International Forum: Bacterial contamination of blood components